Clinical trial
Phase 1 Study of LY2523355 in Patients With Acute Leukemia
NCT01214655 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase 1 Study of LY2523355 in Patients With Acute Leukemia
- Lead sponsor
- Eli Lilly and Company
- Phase
- Phase 1
- Overall status
- Terminated
- Start date
- June 30, 2008
- Completion date
- February 28, 2011
- Enrollment
- 33 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
acute leukemia